Mahalatchimy, Aurélie, Lau, Pin Lean, Li, Phoebe and Flear, Mark L (2021) Framing and legitimating EU legal regulation of human gene-editing technologies: key facets and functions of an imaginary. Journal of Law and the Biosciences, 8 (2). pp. 1-30. ISSN 2053-9711
![]() |
PDF
- Accepted Version
Download (401kB) |
![]() |
PDF
- Published Version
Available under License Creative Commons Attribution-NonCommercial No Derivatives. Download (507kB) |
Abstract
Gene-editing technologies, ie those able to make changes in the DNA of an organism, are the object of global competition and a regulatory race between countries and regions. There is an attempt to craft legal frameworks protective enough for users, but flexible enough for developers of gene-editing technologies. This article examines the imaginary built into the framing of EU-level legal regulation of human gene-editing technologies and identifies its three key related facets: the tension around naturalness; safeguarding morality and ethics; and the pursuit of medical objectives for the protection of human health. Concerns around the use of gene-editing technologies in relation to eugenics and human enhancement have produced a multifaceted imaginary. We argue that this imaginary not only places a limit on EU-level regulation, despite a strong EU competence in respect of the internal market, but also seeks to ensure its legitimation.
Item Type: | Article |
---|---|
Keywords: | Gene editing, Imaginaries, European Union, Framing, Law, Science and Technology Studies |
Schools and Departments: | School of Law, Politics and Sociology > Law |
Research Centres and Groups: | Centre for Global Health Policy |
SWORD Depositor: | Mx Elements Account |
Depositing User: | Mx Elements Account |
Date Deposited: | 12 Nov 2020 07:48 |
Last Modified: | 25 Feb 2022 13:17 |
URI: | http://sro.sussex.ac.uk/id/eprint/94995 |
View download statistics for this item
📧 Request an updateProject Name | Sussex Project Number | Funder | Funder Ref |
---|---|---|---|
Biomodifying technologies and experimental space: organisational and regulatory implications for the translation and valuation of health research | G2291 | ESRC-ECONOMIC & SOCIAL RESEARCH COUNCIL | ES/P002943/1 |
Biomodifying technologies: Governing converging research in the life sciences | G2501 | LEVERHULME TRUST | RPG-2017-330 |